1. THE EFFICACY OF IBRUTINIB IN PATIENTS WITH RELAPSED MANTLE CELL LYMPHOMA AFTER FIRST LINE INTENSIVE CHEMO‐IMMUNOTHERAPY AND ASCT – A RETROSPECTIVE STUDY FROM THE LWP‐EBMT. (12th June 2019) Authors: Burney, C.N.; Robinson, S.; Boumendil, A.; Finel, H.; Khvedelidze, I.; Hunter, H.; Poire, X.; Lioure, B.; Peggs, K.; Foa, R.; Pillai, S.; van Meerten, T.; Bargay Lleonart, J.; Schmid, C.; Vergote, V.; Ganser, A.; Castagna, L.; Mufti, G.; Montoto, S. Journal: Hematological oncology Issue: Volume 37(2019)Supplement 2 Page Start: 243 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗